Capstan Therapeutics, Inc.
Biotechnology
Capstan Therapeutics is developing in vivo RNA-based therapies for oncology, fibrosis, and inflammation-related diseases. Its platform utilizes targeted lipid nanoparticles for precise delivery and control of engineered cells, aiming to advance innovative treatments in these fields.
Founded: 2021
Laura Shawver Ph.D. President & Chief Executive Officer |
Justin Thacker Chief Financial Officer |
Priya Karmali Ph.D. Chief Technology Officer |
Adrian Bot Ph.D. Founding Chief Scientific Officer, Executive Vice President of Research & Development |
Haig Aghajanian Ph.D. Co-Founder & Vice President of Research |
Ramin Farzaneh-Far MD Chief Medical Officer |